CJC-1295, Ipamorelin and Tirzepatide: What UK Patients Need to Know (October 2026)

01 · The short answer

Can you take CJC-1295 and ipamorelin with tirzepatide?

The licensed information for Mounjaro describes tirzepatide on its own, alongside a reduced-calorie diet and increased physical activity.¹ It does not describe growth-hormone-related peptides as part of treatment.

That is not the same as saying a combination is proven harmful. It means nobody can give you a reliable account of the benefits or the risks. Anyone who tells you exactly how the two behave together, with precise results, is going beyond the licensed evidence.

If you already use either peptide and are considering Mounjaro, the safest step is to tell the prescriber reviewing your consultation. A prescriber can only judge suitability on what they know about everything you take.

02 · Comparison

Tirzepatide versus the peptide stack at a glance

03 · What to do next

What to do if you want the licensed route

If your goal is weight management, the evidence-backed option on our side is tirzepatide itself. Our weight loss clinic explains the options, and you can read about the Mounjaro pen before starting a free online consultation. Your prescriber reviews your suitability and everything else you take before anything is dispensed.

Related guides: Mounjaro Single Pen UK - All Doses Available and Do vapes suppress appetite and Does strattera suppress appetite and Does lorazepam suppress appetite and Does meth suppress appetite.

04 · What tirzepatide does

What tirzepatide actually does

Tirzepatide is the active ingredient in Mounjaro, a once-weekly injectable prescription medicine made by Eli Lilly. In the UK it is licensed for weight management in adults and for type 2 diabetes. It comes as a pre-filled multi-dose pen (KwikPen) in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.¹

It is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin. In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.¹

That mechanism is what separates tirzepatide from anything marketed as a peptide stack.

The headline trial figures come from SURMOUNT-1. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² These are trial averages. Individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.

05 · Is CJC-1295 a GLP-1?

Is CJC-1295 a GLP-1?

No. CJC-1295 is not a GLP-1 medicine. GLP-1 medicines act on the receptor for a gut hormone involved in appetite and blood sugar. Tirzepatide does this and also acts on the GIP receptor.¹

CJC-1295 and ipamorelin are usually described by sellers as growth-hormone-related peptides, a different family from GLP-1 medicines. That is a different family of compounds with a different intended purpose. Because the names sound similar to "semaglutide" or "tirzepatide" in online listings, some people assume they are cousins. They are not interchangeable and one cannot stand in for the other.

This matters when you are reading product pages. A listing that calls a peptide "GLP-1 like" or "nature's Mounjaro" is making a marketing claim, not stating a licensed fact. Only medicines with a UK marketing authorisation have product information you can check, and Mounjaro's is published for anyone to read.

The same caution applies to the stack name. CJC-1295 and ipamorelin are often sold together as a pair, but a blend is not a licensed product, and a combined label does not tell you what you are actually receiving.

06 · Does it suppress appetite?

Does CJC-1295 with ipamorelin suppress appetite?

For tirzepatide, reduced hunger is part of the documented mechanism.¹ CJC-1295 and ipamorelin are not licensed appetite treatments; ask your prescriber.

If appetite control is what you need, the licensed route is the one with a documented mechanism and a body of trial data.

07 · Muscle and body composition

The muscle-preservation argument

The main reason people pair peptides with tirzepatide is the hope of protecting lean muscle while losing weight. It is an understandable worry, because weight loss from any method can include some loss of lean tissue.

The benefit of these peptides for protecting muscle is unproven.

What the licensed information does support is that tirzepatide works alongside a reduced-calorie diet and increased physical activity.¹ The activity part of that sentence is where most people can act on muscle. Regular resistance-style activity and adequate food intake are things to plan with your prescriber, who can advise on what suits your health and your dose.

If you are concerned about muscle, say so during your reviews. Ask how your pace of weight loss looks and whether your dose is appropriate. Those are practical, answerable questions. "Which peptide protects muscle?" currently is not.

Also remember that SURMOUNT-1 results are trial averages. Your own result depends on dose, diet, activity and individual response, and trial averages do not predict your own result.²

08 · Safety and sourcing risks

Safety and sourcing risks with peptide products

The biggest practical risk with peptide stacks is not the theory but the supply chain. Products sold online as research chemicals, "peptide blends" or cosmetic items do not come with the checks that apply to licensed medicines.

The MHRA publishes counterfeit medicine alerts and runs the Yellow Card scheme for reporting suspected side effects.⁷ That is the right place to look if a product made you unwell or you suspect it is not what it claims to be. You can report a side effect through Yellow Card.¹⁹

Warning signs worth treating seriously:

• A seller offering to supply without a consultation or prescription.
• Dramatic weight-loss claims, or promises of specific results.
• No clear information about who made the product or where it was stored.
• Blends where the label does not state exactly what each vial contains.
• Prices far below anything a regulated supplier could offer.

You can check any UK pharmacy on the GPhC register. Ours is GPhC 9012878, and the register entry is public.

09 · Telling your prescriber

Why you must tell your prescriber what else you use

Your prescriber can only assess suitability for Mounjaro on the information you give them. Anything you inject or take, whether licensed, unlicensed or bought online, belongs in that conversation.

The patient information leaflet for Mounjaro asks you to tell your doctor or pharmacist about other medicines you use.¹³ That includes peptides, supplements and products from overseas sellers.

A few practical points:

• Say which products you use, how you obtained them and how long you have used them.
• Mention any symptoms you have noticed, even if you are unsure they are related.
• If you are on diabetes medicines such as insulin or sulfonylureas, doses may need adjusting because of the risk of low blood sugar.¹
• Tell your prescriber if you take oral contraceptives, because the medicine can reduce their absorption as stomach emptying slows.¹ The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.¹

Our ongoing monthly reviews, dose-titration and follow-up assessments are there to catch problems early, with side-effect support from the prescribing team.

10 · Licensed route and the NHS

The licensed route: private and NHS

Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴⁶ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.

Private treatment through a UK pharmacy means the medicine is a licensed product and the consultation is reviewed by a GPhC-registered prescriber. With us, the process runs like this:

• A free online consultation: a short health questionnaire, no charge and no obligation.
• Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full.
• Dispensing and dispatch by our registered pharmacy, with same-day dispatch when ordered by 3pm.
• Free next-day tracked delivery in discreet, temperature-controlled packaging.

Our Mounjaro comes through official LillyDirect supply, direct from Eli Lilly's UK distribution, as genuine KwikPens. All six doses are in stock.

11 · Questions to ask before adding anything

Questions to ask before adding anything to tirzepatide

If you are tempted by a stack or any add-on, a short list of questions cuts through marketing quickly. Take them to your prescriber or pharmacist.

Is the product licensed in the UK, and can I read its product information? For Mounjaro you can read the SmPC and patient leaflet. For a blended peptide there is nothing equivalent to check.

What is the evidence, by name? A real claim points to a named trial. If a seller cannot name a trial, treat benefits as unproven.

Does it change what I should do about diet and activity? Tirzepatide is used alongside a reduced-calorie diet and increased physical activity. No add-on replaces those.¹

Who is monitoring me? A regulated service gives you reviews, dose adjustment and a route to report problems. A product bought from a stranger does not.

What happens if I stop? After a final tirzepatide dose, it takes roughly four to five weeks to clear the system, and nothing needs doing while it clears.¹

12 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹